Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia (AMG102)

This study is currently recruiting participants.
Verified May 2012 by AMG Medical Inc.
Sponsor:
Information provided by (Responsible Party):
AMG Medical Inc.
ClinicalTrials.gov Identifier:
NCT01556594
First received: March 15, 2012
Last updated: May 14, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)